Skip to main content
For Pulmonologists
For Rheumatologists
PulmonaryFibrosis360
pulmonaryfibrosis360
PulmonaryFibrosis360
pulmonaryfibrosis360
  • About
    CTD-ILDs

    About 
    CTD-ILDs

    In this section, you will learn about the disease behavior and impacts of pulmonary fibrosis on your patients with CTD-ILDs.

    • About
      CTD-ILDs
    • Interplay of inflammation and fibrosis
    • Progression and self-sustaining fibrosis in CTD-ILDs
    • Prevalence of CTD-ILDs
    • Fibrosing CTD-ILDs with a progressive phenotype
    • Impact of CTD-ILDs
    • CTD-ILD patient cases
    Impact of CTD-ILDs
    Increased mortality rates

    Understand the survival impacts of pulmonary fibrosis on your patients with CTD-ILDs

  • Diagnosis & management
    of CTD-ILDs

    Diagnosis & management
    of CTD-ILDs

    In this section, you will find out about the recommended ways you can identify, monitor and manage ILD in your CTD patients.

    • Diagnosis & management
      of CTD-ILDs
    • Screening for ILD in CTDs
    • Diagnosis of CTD-ILDs
    • HRCT imaging in CTD-ILDs
    • Monitoring and management of ILD progression in CTD-ILDs
    • Multidisciplinary team resources
    • Palliative/supportive care
    Screening for ILD in CTD-ILDs
    Screening for ILD in SSc

    Different ILD screening strategies are given for specific CTDs

  • SSc-ILD

    SSc-ILD

    In this section, you will find out about the impacts of SSc-ILD, and how you can screen for, diagnose and manage ILD in your SSc patients.

    • SSc-ILD
    • Common pathophysiology of fibrotic CTD-ILDs
    • Prevalence of SSc-ILD
    • Impact of SSc-ILD
    • Screening for ILD in SSc
    • Diagnosis of SSc-ILD
    • Management of SSc-ILD
    • Ongoing monitoring in SSc-ILD
    Screening for ILD in SSc
    Management of SSc-ILD


    ILD is the leading cause of death in SSc — screen all SSc patients for ILD

  • RA-ILD

    RA-ILD

    In this section, you will find out about the impacts of RA-ILD, and how you can screen for, diagnose, monitor and manage ILD in your RA patients.

    • RA-ILD
    • Common pathophysiology of fibrotic CTD-ILDs
    • Prevalence of RA-ILD
    • Impact of RA-ILD
    • Screening for ILD in RA
    • Diagnosis of RA-ILD
    • Monitoring and management of ILD progression in RA-ILD
    Screening for ILD in RA
    Screening for ILD in RA

    Algorithm to identify ILD in patients with RA

  • Primary
    Sjörgren's-ILD

    Primary
    Sjörgren's-ILD

    In this section, you will find out about the impacts of pSS-ILD, and how you can screen for, diagnose, monitor and manage ILD in your pSS patients.

    • Primary
      Sjörgren's-ILD
    • Common pathophysiology of fibrotic CTD-ILDs
    • Prevalence of pSS-ILD
    • Impact of pSS-ILD
    • Screening for ILD in pSS
    • Diagnosis of pSS-ILD
    • Monitoring and management of ILD progression in pSS-ILD
    Screening for ILD in pSS
    pl

    Algorithm to screen for and identify ILD in patients with pSS

  • For Pulmonologists
  • For Rheumatologists

    See all results

    Sitemap

    • Interplay of inflammation and fibrosis
    • Progression and self-sustaining fibrosis in CTD-ILDs
    • Prevalence of CTD-ILDs
    • Fibrosing CTD-ILDs with a progressive phenotype
    • Impact of CTD-ILDs
    • CTD-ILD patient cases
    • Screening for ILD in CTDs
    • Diagnosis of CTD-ILDs
    • HRCT imaging in CTD-ILDs
    • Monitoring and management of ILD progression in CTD-ILDs
    • Multidisciplinary team resources
    • Palliative/supportive care
    • Common pathophysiology of fibrotic CTD-ILDs
    • Prevalence of SSc-ILD
    • Impact of SSc-ILD
    • Screening for ILD in SSc
    • Diagnosis of SSc-ILD
    • Management of SSc-ILD
    • Ongoing monitoring in SSc-ILD
    • Common pathophysiology of fibrotic CTD-ILDs
    • Prevalence of RA-ILD
    • Impact of RA-ILD
    • Screening for ILD in RA
    • Diagnosis of RA-ILD
    • Monitoring and management of ILD progression in RA-ILD
    • Common pathophysiology of fibrotic CTD-ILDs
    • Prevalence of pSS-ILD
    • Impact of pSS-ILD
    • Screening for ILD in pSS
    • Diagnosis of pSS-ILD
    • Monitoring and management of ILD progression in pSS-ILD
    logo-bi-contrast
    http://pulmonaryfibrosis360.com
    • Privacy notice
    • Terms of use
    • Sitemap
    • Contact us
    • Accessibility statement 

    Use of this site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Notice.

    ©2010-2023 Boehringer Ingelheim International GmbH. All rights reserved.